// App-Quantinova.ai

: Assay Development and Small Molecule Screens for Inhibitors of an RNA Binding Protein Implicated in Hematologic Malignancies

Researchers

Presenter

  • Sean M. Post

Principal Investigators

  • Lauren E. Chan

  • xiaorui zhang

  • Oscar Benitez

  • Kerstin Rahn

  • Todd Link

  • Clifford Stephan

  • Eun Cho

  • Kevin Dalby

  • Prerna Malaney

Medical Centers

  • Department of Leukemia, MD Anderson, Houston, TX

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

  • UT Austin, Austin

  • MD Anderson, Houston

  • Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX

  • Department of Intensive Care Medicine, University Hospital RWTH Aachen University, Aachen, Germany

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Acute myelocytic leukemia

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

  • cMYC

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved